Skip to content
Home/Companies/Biotech/Stragen
ST

Stragen

Biotech·Switzerland·Active·5yr hold

Stragen is a biopharma products company, headquartered in Switzerland.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Stragen?

Stragen is currently owned by ARCHIMED through MED III (2021 vintage), since 2021.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED III · 2021 · Buyout

Key facts

HQSwitzerland
SectorBiopharma Products

More from MED III

Other portfolio companies in the same fund.

BioVendor Group
Active
MedTechCzech Republic· 2025
DermaPharm
Active
HealthTechDenmark· 2025
Natus Sensory
Active
MedTechUS· 2022
PlasmidFactory
Active
BiotechGermany· 2022
Title21 Health Solutions
Active
HealthTechUS· 2022
Aliri
Active
PharmaUS· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings